[Tumor markers in urological malignancies].
Present status of tumor markers in urological malignancies for diagnosis and follow-up was reviewed. Although many researches have been performed, specific tumor markers in kidney, urothelium and penis cancers have not identified. In testicular tumors, AFP and beta-subunit of HCG are widely used. Especially, using biological half time, these substances are very useful in the judgement of presence of residual tumor or tumor recurrence. In prostate cancer, the determination of PSA has been confirmed to be the most useful tumor marker in solid tumor. World standardization of PSA assays and evaluation of PSA subtypes are necessary.
Kuriyama
M
M
Department of Urology, Gifu University School of Medicine.
D014408:Biomarkers, Tumor / Q000032:analysis*; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis; D013736:Testicular Neoplasms / Q000175:diagnosis; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis; D014571:Urologic Neoplasms / Q000175:diagnosis*
D014408:Biomarkers, Tumor